Public Company News

Explore the World: Tripadvisor's Top Destinations for 2026

From Bali to New York, Travelers Share Their Favorite Spots for Adventure, Romance, and Culture NEEDHAM, Mass., Jan. 13, 2026 /PRNewswire/ -- Tripadvisor®, the world's largest travel guidance platform, today announced its first Travelers' Choice® Awards category for 2026:Best of the Best Destina...

2026-01-13 13:01 3434

CDP grants Grupo Rotoplas its highest Climate Action Rating

MEXICO CITY, Jan. 12, 2026 /PRNewswire/ -- Grupo Rotoplas, S.A.B. de C.V. (BMV: AGUA*) ("Rotoplas" or "The Company"), leader in water management solutions in the Americas, announces that it has received an "A" rating, the highest possible score, in CDP's 2025 Climate Change Questionnaire. This...

2026-01-13 11:40 2334

WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic

WUXI, China, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 (DP5) and Drug Product Packaging Center (DPPC) – have r...

2026-01-13 11:07 3897

WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic

WUXI, China, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 (DP5) and Drug Product Packaging Center (DPPC) – have r...

2026-01-13 11:07 5803

SMAR Investors Have Opportunity to LeadSmartsheet Inc. Securities Lawsuit

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds all former stockholders of Smartsheet Inc. (NYSE: SMAR) in connection with the January 2025 sale (the "Merger" or "Buyout") of Smartsheet to affiliates of investment funds managed by affilia...

2026-01-13 10:00 2434

Vistra Prices Private Offering of $2.250 Billion of Senior Secured Notes

IRVING, Texas, Jan. 12, 2026 /PRNewswire/ -- Vistra Corp. (NYSE: VST) (the "Company" or "Vistra") announced today the pricing of a private offering (the "Offering") of $2.25 billion aggregate principal amount of senior secured notes, consisting of $1.0 billion aggregate principal amount of senior...

2026-01-13 09:49 1973

SMAR INVESTOR ALERT: Former Smartsheet Inc. Shareholders with Substantial Holdings Have Opportunity to Lead the Smartsheet Class Action Lawsuit

SAN DIEGO, Jan. 12, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that Smartsheet Inc...

2026-01-13 09:33 2312

BTDR Investors Have Opportunity to LeadBitdeer Technologies Group Securities Fraud Lawsuit

NEW YORK, Jan. 12, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitdeer Technologies Group (NASDAQ: BTDR) between June 6, 2024 and November 10, 2025, both dates inclusive (the "Class Period"), of the important February 2, 202...

2026-01-13 09:00 2454

Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- 13 January 2026 (Beijing Time), Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announcedtoday that the New Drug Application (NDA) for its novel, orally administered, highly selective, and potent small-molecule colony-...

2026-01-13 08:54 3465

Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- 13 January 2026 (Beijing Time), Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announcedtoday that the New Drug Application (NDA) for its novel, orally administered, highly selective, and potent small-molecule colony-...

2026-01-13 08:54 1988

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Varonis Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -VRNS

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, both dates inclusive (the "...

2026-01-13 08:32 1481

MISSION BANK OPENS NEW OFFICE IN NORTH SAN LUIS OBISPO COUNTY

BAKERSFIELD, Calif., Jan. 12, 2026 /PRNewswire/ -- Mission Bank has expanded existing operations in the Central Coast with the addition of a Loan and Deposit Production team located in North San Luis Obispo County. Led by Mark Pearce, and joined by Relationship Managers Sarah Kramer and Katie ...

2026-01-13 08:28 1670

AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans

* AbbVie will provide low prices in Medicaid, and expand affordable, direct-to-patient offerings for treatments used by millions of Americans through TrumpRx * AbbVie will commit $100 billion in U.S. research and development (R&D) and capital investments, including manufacturing, over the nex...

2026-01-13 07:30 1722

Secretary of War Visits Lockheed Martin F-35 Production Facility

FORT WORTH, Texas, Jan. 12, 2026 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) welcomed Secretary of War Pete Hegseth to the Fort Worth, Texas, F-35 Lightning II production facility today. The visit was part of the secretary's Arsenal of Freedom industry tour and underscored Lockheed Martin's role ...

2026-01-13 06:43 1503

DEFT Investors Have Opportunity to Lead DeFi Technologies, Inc. Securities Fraud Lawsuit

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofDeFi Technologies, Inc. (NASDAQ: DEFT) between May 12, 2025 and November 14, 2025, both dates inclusive (the "Class Period"), of the important January 30, 2026 lea...

2026-01-13 06:41 1587

KLAR INVESTOR ALERT: Hagens Berman Notifies Klarna Group plc (KLAR) Investors of Feb. 20 Deadline in IPO Securities Class Action

SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors inKlarna Group plc (NYSE: KLAR) of the upcomingFebruary 20, 2026, lead plaintiff deadline in a pending securities class action. The firm is actively investigating the lawsuits cl...

2026-01-13 06:41 1498

PRGO Deadline: PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026 lead...

2026-01-13 06:40 1482

Datasea Announces Major Acoustic Technology Advancements in Brain-Computer Interface Applications

Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface Market BEIJING, Jan. 12, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in aco...

2026-01-12 22:30 1827

PlayNitride and Brillink Announce Strategic Collaboration to Advance Array-Based Photonic Interconnects

HSINCHU and MIAOLI, Jan. 12, 2026 /PRNewswire/ -- PlayNitride, a global leader in MicroLED technologies, today announced a strategic collaboration with Brillink to develop a next-generation array-based photonic interconnect solution designed to deliver longer reach, lower power consumption, and ...

2026-01-12 22:00 263

Insilico Medicine Completes First Patient First Dose in BETHESDA: A Phase II Trial for Garutadustat (ISM5411), the Gut-restricted AI-driven PHD Inhibitor for the Treatment of Inflammatory Bowel Disease

CAMBRIDGE, Mass., Jan. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the completion of first patient first dose in BETHESDA: a Phase IIa clinical trial of ISM5411 (NCT07265570

2026-01-12 21:30 1523
1 ... 12131415161718 ... 774